PROTOCOLOS DE PCR MULTIPLEX PARA GRAM POSITIVOS
Protocolo de PCR multiplex para la detección de genes vanA, vanB, vanC1, vanC2/3 Detección multiplex vanA-B-C-16S
Outbreak of Serratia marcesens co-producing NDM-1 plus OXA-48-like carbapenemases in an
Interzonal General Hospital
Outbreak of Serratia marcesens co-producing NDM-1 plus OXA-48-like carbapenemases in anInterzonal General Hospital
Multicenter, Prospective Study of Carbapenemase-Producing Enterobacterales (CPE) in the
COVID-19 Era in Argentina (RECAPT-AR)
Multicenter, Prospective Study of Carbapenemase-Producing Enterobacterales (CPE) in theCOVID-19 Era in Argentina (RECAPT-AR)
Enterobacterales bacteremias in oncohematological patients: Can we predict the outcome
according to the etiology?
Enterobacterales bacteremias in oncohematological patients: Can we predict the outcomeaccording to the etiology?
Emergence of optrA-mediated linezolid resistance in Enterococcus faecalis clinical isolates from
Argentina
Emergence of optrA-mediated linezolid resistance in Enterococcus faecalis clinical isolates fromArgentina
Emergence of carbapenemase-producing Klebsiella pneumoniae clinical isolates with a pan-drug
resistant (PDR) phenotype in Argentina
Emergence of carbapenemase-producing Klebsiella pneumoniae clinical isolates with a pan-drugresistant (PDR) phenotype in Argentina
Comparison of Methods to Determine Acinetobacter Cefiderocol (CFD) Susceptibility: are the
results comparable between the different assays?
Comparison of Methods to Determine Acinetobacter Cefiderocol (CFD) Susceptibility: are theresults comparable between the different assays?
Comparison of iron-depleted (ID) versus cation-adjusted Mueller-Hinton broth (CAMHB)
media for cefiderocol susceptibility among carbapenemase-producing Enterobacterales (CPEs)
Comparison of iron-depleted (ID) versus cation-adjusted Mueller-Hinton broth (CAMHB)media for cefiderocol susceptibility among carbapenemase-producing Enterobacterales (CPEs)
Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producing
Enterobacterales bacteremia in high-risk neutropenic patients
Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producingEnterobacterales bacteremia in high-risk neutropenic patients
Bacteremia in cancer patients: Has the COVID-19 pandemic changed the epidemiology?
Bacteremia in cancer patients: Has the COVID-19 pandemic changed the epidemiology?
Activity of cefiderocol against carbapenemase-producing Enterobacterales (CPE) in the post
COVID-19 era: results of a prospective, multicenter study in Argentina
Activity of cefiderocol against carbapenemase-producing Enterobacterales (CPE) in the postCOVID-19 era: results of a prospective, multicenter study in Argentina
Activity in vitro of new beta-lactam beta-lactamase inhibitor combinations against Burkholderia cepacia Complex (Bcc) and Burkholderia gladioli (Bgl) isolated from patients with cystic fibrosis
Activity in vitro of new beta-lactam beta-lactamase inhibitor combinations against Burkholderiacepacia Complex (Bcc) and Burkholderia gladioli (Bgl) isolated from patients with cystic fibrosis